First Phase III study to show that a cancer immunotherapy improves disease-free survival in people with resectable early stage lung cancer compared to best supportive […]
Merck today announced that Rehan Verjee has made the decision to leave his position as President of EMD Serono and Global Head of Innovative Medicine […]
….for Patients with Metastatic NSCLC with METex14 Skipping Alterations Merck today announced that the US Food and Drug Administration (FDA) has approved TEPMETKO® (tepotinib) following […]
The Chinese National Medical Products Administration (NMPA) has approved Nubeqa™ (darolutamide) for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who are at […]
Today, on the eve of the World Cancer Day, the European Commission is presenting Europe’s Beating Cancer Plan – a main priority in the area […]
The European Investment Bank (EIB) will provide €20 million to finance the research, development and innovation (RDI) programme of Galenicum, a pharmaceutical company founded in […]
Designed to provide guidance around evolving digital business models, the panel will address digital ethics questions for all three business sectors of Merck. Merck, a […]
SpaceX launched its 21st commercial resupply mission to the International Space Station at 11:17 a.m. EST Dec. 6, 2020, from Launch Pad 39A at NASA’s […]
Merck and Artios today announced a global three year strategic research collaboration to discover and develop multiple precision oncology drugs. • Merck and Artios will […]
The Commission has today adopted a Pharmaceutical Strategy for Europe to ensure patients have access to innovative and affordable medicines and to support the competitiveness, […]
To create a more robust mandate for coordination by the Commission and EU agencies, the Commission is today proposing a new Regulation on serious cross-border […]
The European Centre for Disease Control and Prevention and the European Medicines Agency have been at the forefront of the EU’s work to address COVID-19 […]
Copyright © 2021 | WordPress Theme by MH Themes